Propyl Gallate

棓丙酯

Report date: 2023/02/15 15:56:47
NME

Base Information

Drug NamePropyl Gallate
Drug Alias Name3，4，5-三羟基苯甲酸丙酯
ClassificationSmall molecules
Mechanisms of ActionEstrogen receptors antagonists
TargetsEstrogen receptors
Therapy Area/IndicationsThrombophlebitisCoronary DiseaseInfarction, Middle Cerebral Artery
Global Approved IndicationsThrombophlebitisCoronary DiseaseInfarction, Middle Cerebral Artery
Approved Indications in ChinaThrombophlebitisCoronary DiseaseInfarction, Middle Cerebral Artery
Original Approved Country/TerritoryMainland China
Original Approved Date1996/01/01
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesBeijing Sihuan Kebao Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesFujian Mindong Rejuvenation Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsThrombophlebitisCoronary DiseaseInfarction, Middle Cerebral Artery
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A